Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T20:21:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T20:44:12.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating access is denied to the record. Several key study documents and related links were removed from the page, reducing publicly available information about the trial.
    Difference
    16%
    Check dated 2026-09-23T21:50:50.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new page revision identifier v3.7.0 has been added, replacing the previous v3.6.6. This appears to be a technical/metadata update to the page rather than a change to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-16T21:41:07.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added on the page, replacing Revision: v3.6.5. This signals a new build of the platform without changes to the study content or data.
    Difference
    0.0%
    Check dated 2026-09-02T19:34:37.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Adds NIH grant/contract year annotations for 2019 and 2023 to the study's funding details. These entries provide context for the funding identifiers associated with the trial.
    Difference
    0.0%
    Check dated 2026-08-26T16:43:44.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.